Search results
Results from the WOW.Com Content Network
Opening Science. PLOS is a nonprofit, Open Access publisher empowering researchers to accelerate progress in science and medicine by leading a transformation in research communication. About PLOS. Every country. Every career stage. Every area of science.
Supported by article-level-metrics to track the reach and influence of your work with precision. Indexed widely by major services such as Crossref, Dimensions, DOAJ, Google Scholar, PubMed Central, Scopus, Web of Science, and many more. Eligible for preprint-posting.
PLOS publishes a suite of influential Open Access journals across all areas of science and medicine. Rigorously reported, peer reviewed and immediately available without restrictions, promoting the widest readership and impact possible.
Editor Spotlight: Apurvakumar Pandya. In this interview, PLOS ONE Academic Editor Apurvakumar Pandya shares his insights on PLOS’ role in promoting public mental health, his research focus on mental health equity, and the importance of mentorship in becoming proficient practitioners and researchers.
PLOS is a nonprofit, Open Access publisher empowering researchers to accelerate progress in science and medicine by leading a transformation in research communication. We’ve been breaking boundaries since 2001.
Resources For Editors. GET STARTED AS AN EDITOR. Editorial Board Members for PLOS. Are engaged, active volunteers who are committed to their journal’s mission. They are open to innovation in scientific communications, and are eager to contribute ideas and lend their expertise in service to research communities.
Reusable methods and protocols (PRO-MaP) This Perspective article describes PRO-MaP, which aims to increase and improve the reporting of detailed, structured and open methods and reusable step-by-step protocols in the life sciences. Image credit: European Union.
Open Access returns us to the values of science: to help advance and improve society. By providing immediate and unrestricted access to the latest research, we can accelerate discovery and create a more equitable system of knowledge that is open to all.
The PLOS ONE Editors. No evidence for a difference in Bayesian reasoning for egocentric versus allocentric spatial cognition. James Negen. Efficacy and safety of pembrolizumab in cervical cancer: Protocol for systematic review and meta-analysis of randomized clinical trials.
PLOS ONE accepts research in over two hundred subject areas across science, engineering, medicine, and the related social sciences and humanities. We evaluate research on the basis of scientific validity, strong methodology, and high ethical standards—not perceived significance. Multidisciplinary and interdisciplinary research, replication ...